Chinese Court Orders Compensation For Death Due To Taking Large Pill (China)
This article was originally published in PharmAsia News
Executive SummaryA Shanghai court ordered Yangwenshui Pharmaceutical to pay $7,512 to the family of a woman who choked to death on one of the company's large pills. The woman's husband filed a suit against the company on grounds it should have warned her of the risks of taking a pill that size. The company countered the woman should have been aware of how to take the pill, 1.6 centimeters in diameter. Yangwenshui also said the drug was made in accordance with state standards. (Click here for more ) "Drugmaker Told To Pay Victim Kin For Fatal Pill" Shanghai Daily (China) (12/7/07)
You may also be interested in...
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced January 2020.
Industry experts expect a continued uptick in deals valued between $2bn-$10bn this year as buyers look to add critical mass in areas like oncology, rare disease and cell and gene therapy. Divestitures to free up capital and narrow focus should continue too.
UK-centric investment firm Syncona’s model of “founding, building and funding” early-stage biotech companies – with a commitment to the longer term – hopes to help make Great Britain a cell and gene therapy powerhouse.